|
|
Article: Solvay Subscribes to a CustomSuite of Gene Logic's BioExpress System.
- Article from:
- Business Wire
- Article date:
- May 28, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
GAITHERSBURG, Md.--(BUSINESS WIRE)--May 28, 2003
Gene Logic Inc. (Nasdaq:GLGC) today announced that Solvay Pharmaceuticals ("Solvay"), a division of Solvay S.A., an international chemical and pharmaceutical group based in Brussels, has subscribed to a CustomSuite product from Gene Logic's BioExpress(TM) System.
Solvay will apply this data resource to selected areas of their target discovery research efforts. Financial details of the multiyear subscription agreement were not disclosed.
The subscription agreement gives Solvay researchers access to a customized information ...